GSK to drive growth in emerging markets with acquisition of UCB products

GSK in talks to acquire Nuvalent for over $9 billion in largest deal in more than a decade

GSK is in talks to acquire biotech firm Nuvalent for more than $9 billion, which would be its largest acquisition in over a decade and the s

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

Merck KGaA acquires Bio-Techne in $11 billion all-cash deal to bolster life sciences division

Merck KGaA has agreed to acquire Bio-Techne for approximately $11 billion in an all-cash deal, aiming to strengthen its life sciences portfo

Global Invests in Modular Capability with Acquisition of Pier Solutions as it Launches Global Modular

Private-equity firm acquires $1.6 billion Irca as Dubai chocolate trend fuels growth

Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal